Literature DB >> 8493775

Growth hormone (GH) and prolactin (PRL) gene expression and immunoreactivity in GH- and PRL-producing human pituitary adenomas.

J Li1, L Stefaneanu, K Kovacs, E Horvath, H S Smyth.   

Abstract

Growth hormone(GH)-producing pituitary adenomas are morphologically heterogeneous and frequently contain not only GH immunoreactivity but also variable numbers of prolactin (PRL) immunopositive cells. Paraffin sections of 59 surgically removed GH- and/or PRL-producing adenomas classified by histology, immunocytochemistry (ICC) and electron microscopy were studied using in situ hybridization (ISH) for GH and PRL mRNA and combined with ICC for the coded hormones. Somatotroph adenomas (10 densely and 10 sparsely granulated tumours) and mammosomatotroph adenomas (10 cases) contained both GH mRNA and GH immunoreactivity. In 4 densely and 4 sparsely granulated somatotroph adenomas and 4 mammosomatotroph adenomas, only GH mRNA and its product were found. In 28 cases (6 densely and 6 sparsely granulated somatotroph adenomas, 10 mixed somatotroph-lactotroph adenomas and 6 mammosomatotroph adenomas) both GH and PRL mRNA were present, although no PRL immunoreactivity was not in 2 densely granulated somatotroph adenomas. In these cases, ISH for PRL mRNA combined with GH immunostaining revealed the presence of variable numbers of mammosomatotrophs. In 9 acidophil stem cell adenomas only PRL mRNA and its product were found; one tumour expressed both GH and PRL mRNA and their products. Nine lactotroph adenomas contained only PRL mRNA and PRL immunoreactivity. The results show that GH and/or PRL mRNA content could not be correlated with ICC for coded proteins and ultrastructural features. The mammosomatotrophs were more numerous using ISH when compared with ICC. Somatotroph, mammosomatotroph and mixed adenomas are closely related and they can be considered to represent one basic tumour type originating in a cell committed to GH production. This may undergo clonal differentiation towards a mammosomatotroph and further to the lactotroph line. The results also indicate that lactotroph adenomas arise in a cell committed to PRL production. Acidophil stem cell adenomas seem to be more closely related to lactotroph cells than somatotroph.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8493775     DOI: 10.1007/BF01621802

Source DB:  PubMed          Journal:  Virchows Arch A Pathol Anat Histopathol        ISSN: 0174-7398


  33 in total

1.  Effect of dopamine agonist medication on prolactin producing pituitary adenomas. A morphological study including immunocytochemistry, electron microscopy and in situ hybridization.

Authors:  K Kovacs; L Stefaneanu; E Horvath; R V Lloyd; I Lancranjan; M Buchfelder; R Fahlbusch
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1991

Review 2.  Pathology of excessive production of growth hormone.

Authors:  B W Scheithauer; K Kovacs; R V Randall; E Horvath; E R Laws
Journal:  Clin Endocrinol Metab       Date:  1986-08

3.  Silent somatotroph adenomas of the human pituitary. A morphologic study of three cases including immunocytochemistry, electron microscopy, in vitro examination, and in situ hybridization.

Authors:  K Kovacs; R Lloyd; E Horvath; S L Asa; L Stefaneanu; D W Killinger; H S Smyth
Journal:  Am J Pathol       Date:  1989-02       Impact factor: 4.307

4.  Morphological studies on mixed growth hormone (GH)- and prolactin (PRL)-secreting human pituitary adenomas. Coexistence of GH and PRL in the same secretory granule.

Authors:  M Bassetti; A Spada; M Arosio; L Vallar; M Brina; G Giannattasio
Journal:  J Clin Endocrinol Metab       Date:  1986-06       Impact factor: 5.958

5.  In situ hybridization study of pro-opiomelanocortin (POMC) gene expression in human pituitary corticotrophs and their adenomas.

Authors:  L Stefaneanu; K Kovacs; E Horvath; R V Lloyd
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1991

6.  Pathology of growth hormone-producing tumors of the human pituitary.

Authors:  K Kovacs; E Horvath
Journal:  Semin Diagn Pathol       Date:  1986-02       Impact factor: 3.464

7.  Analysis of mammosomatotropic cells in normal and neoplastic human pituitary tissues by the reverse hemolytic plaque assay and immunocytochemistry.

Authors:  R V Lloyd; D Anagnostou; M Cano; A L Barkan; W F Chandler
Journal:  J Clin Endocrinol Metab       Date:  1988-06       Impact factor: 5.958

8.  Double-labeling immunogold electron-microscopic study of hormonal colocalization in nontumorous and adenomatous rat pituitaries.

Authors:  N E Losinski; E Horvath; K Kovacs
Journal:  Am J Anat       Date:  1989 Jun-Jul

9.  Detection of prolactin messenger RNA in rat anterior pituitary by in situ hybridization.

Authors:  R V Lloyd; T D Landefeld
Journal:  Am J Pathol       Date:  1986-10       Impact factor: 4.307

10.  Human prolactin. cDNA structural analysis and evolutionary comparisons.

Authors:  N E Cooke; D Coit; J Shine; J D Baxter; J A Martial
Journal:  J Biol Chem       Date:  1981-04-25       Impact factor: 5.157

View more
  11 in total

1.  Structure-function correlations of growth hormone or/and prolactin-producing pituitary adenomas: an in vitro study with the reverse hemolytic plaque assay.

Authors:  E Thodou; G Kontogeorgos; E Kyrodimou; H Salla; L Ramyar; E Vamvassakis; G Piaditis; N Anagnostopoulos; S Tzanis; A Levedis; D Rologis; S L Asa
Journal:  J Endocrinol Invest       Date:  1999-10       Impact factor: 4.256

2.  Combined non-isotopic in situ hybridisation and indirect immunohistochemical analysis of hormone production in the rat pituitary gland.

Authors:  N Sanno; A Matsuno; J Itoh; K Kakimoto; A Teramoto; R Y Osamura
Journal:  Clin Mol Pathol       Date:  1996-02

3.  Two-step development of a pituitary adenoma: from hyperprolactinemic syndrome to Cushing's disease.

Authors:  R G Gheri; W Boddi; F Ammannati; J Olivotto; C Nozzoli; A Franchi; L Bordi; M L Luisi; P Mennonna
Journal:  J Endocrinol Invest       Date:  1997-04       Impact factor: 4.256

4.  A case of pituitary somatotroph adenoma with concomitant secretion of growth hormone, prolactin, and adrenocorticotropic hormone--an adenoma derived from primordial stem cell, studied by immunohistochemistry, in situ hybridization, and cell culture.

Authors:  A Matsuno; T Sasaki; T Mochizuki; T Fujimaki; N Sanno; Y Osamura; A Teramoto; T Kirino
Journal:  Acta Neurochir (Wien)       Date:  1996       Impact factor: 2.216

5.  Macroprolactinoma associated with Cushing's disease, successfully treated with cabergoline.

Authors:  G T'Sjoen; I Defeyter; J Van De Saffele; R Rubens; M Vandeweghe
Journal:  J Endocrinol Invest       Date:  2002-02       Impact factor: 4.256

Review 6.  Molecular pathogenesis of acromegaly.

Authors:  M R Drange; S Melmed
Journal:  Pituitary       Date:  1999-06       Impact factor: 4.107

Review 7.  Molecular determinants of pituitary cytodifferentiation.

Authors:  S L Asa; S Ezzat
Journal:  Pituitary       Date:  1999-05       Impact factor: 4.107

8.  Clinical and cytofunctional classification of pituitary adenomas: proposal of a new classification.

Authors:  N Sanno; A Teramoto; R Y Osamura
Journal:  Acta Neurochir (Wien)       Date:  1996       Impact factor: 2.216

9.  The Pituitary in Gigantism.

Authors:  Bernd W. Scheithauer; Kalman T. Kovacs; Lucia Stefaneanu; Eva Horvath; Laurie A. Kane; William F. Young; Ricardo V. Lloyd; Raymond V. Randall; Dudley H. Davis
Journal:  Endocr Pathol       Date:  1995       Impact factor: 3.943

10.  Octreotide Effect on Growth Hormone and Somatostatin Subtype 2 Receptor mRNAs of the Human Pituitary Somatotroph Adenomas.

Authors:  Lucia Stefaneanu; Kalman Kovacs; Kamal Thapar; Eva Horvath; Shlomo Melmed; Yona Greenman
Journal:  Endocr Pathol       Date:  2000       Impact factor: 3.943

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.